Sangamo Therapeutics Gets FDA Clearance for Investigational NDA for Pain Treatment
Sangamo Therapeutics Gets FDA Clearance for Investigational NDA for Pain Treatment
sangamo therapeutics 獲得 FDA 批准,進行疼痛治療的研究性 NDA。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊